Chaperone-mediated autophagy.
Level 5 - mechanism / opinion, no new human data
Narrative review and methodological protocol of bench research with no clinical trial data.
PubMed 18425454 · doi:10.1007/978-1-59745-157-4_15
What was done
The authors review the biology, regulatory triggers, and measurement strategies for chaperone-mediated autophagy (CMA) in mammalian cells. The paper details how CMA responds to cellular stressors such as prolonged starvation, toxic compounds, and oxidative stress, its decline in aging and neurodegeneration, and the experimental tracking of substrate translocation into isolated lysosomes.
What was found
The abstract reports no numerical metrics or statistical findings. It reports that CMA selectively translocates cytosolic proteins individually across the lysosomal membrane, that CMA activity decreases in aging and Parkinson's disease, and that directly tracking substrate protein translocation into isolated lysosomes provides the most definitive measurement of CMA activity.
Why it matters
This work outlines the mechanistic distinction between CMA and bulk autophagy, establishing standard laboratory criteria for directly quantifying substrate translocation in aging and disease models.
Limits
The abstract presents no primary quantitative data, sample sizes, or clinical measurements, representing a conceptual and methodological overview of preclinical laboratory techniques.
Cited by
- partial Chaperone-mediated autophagy is deeply activated after 2.5 to 3 days of fasting.